EVEN AS the U.S. senate debates on expanding federal
funding for embryonic stem cell research, it may be remembered that the claims professed in many papers of adult stem cells becoming any specialised cells should be taken with a pinch of salt.
The president has lifted the Bush restrictions on federal
funding for embryonic stem cell research.
First, promising to restore the integrity of science while seeking vast medical benefits for many, President Obama repealed the restrictions set by President Bush on the use of federal
funds for embryonic stem cell research.
And in a way, this is not very radical because that's what Bush said in August of 2001 when he became the first president to authorize federal
funds for embryonic stem cell research.
On March 9, 2009, President Obama lifted the ban that had previously restricted the use of federal
funds for embryonic stem cell research on cell lines that had been created after August 9, 2001.
Not exact matches
• President Obama did not go half far enough in lifting the ban against federal
funding for embryonic stem -
cell research.
He decreed that the case brought by researchers Drs James Sherley and Theresa Deisher, along with a number of Christian groups including the Christian Medical Association, should be heard; and ordered an injunction temporarily blocking federal
funding allocated
for human -
embryonic -
stem -
cell research.
Although he never banned this
research outright, President Bush limited federal
funding for research to the
embryonic stem cell lines that existed before August 2001, thus drawing a line at destroying human embryos created after that date.
The year's most prominent science issue, federal support of
embryonic stem cell research, is so controversial that the sons of Ronald Reagan gave dueling speeches at the opposing party conventions; Michael Reagan backs President George W. Bush's policies, including the ban on
funding for research on new
stem cell lines, while Ron supports Senator John Kerry's promise to lift restrictions.
He worries that the ruling could foster an unwelcoming climate that would eventually trickle down to limit
funding for basic
research on
embryonic stem cells.
In granting an injunction to two scientists who oppose widening US government
funding for research on human
embryonic stem cells (hESCs), Judge Royce Lamberth wrote of «simply preserving the status quo».
Although the U.S. government puts stringent restrictions on
funding for research on
embryonic stem cells, individual states such as California have set up institutes to perform that work and general
stem cell studies.
They then argue that «By creating a financial incentive
for embryonic stem cell research — an incentive that by NIH's own admission involves investments of «hundreds of millions of dollars» — and by specifying the precise means by which embryos must be destroyed in order to qualify
for federal
funding, the NIH necessarily and knowingly subjects embryos to a substantial risk of injury or death.»
Collins and others argue not just
for a permanent removal of the injunction to resume
research with confidence, but also
for an extension of the number of
embryonic stem cell lines available to federally
funded researchers.
Under the Obama administration, the number of
embryonic stem cell lines available
for federally
funded research had more than tripled, but no money was going toward the creation of any
cell lines (a process that destroys the embryo).
Human
embryonic stem cell (hESC)
research had been backed by federal
funds for more than a decade, but a surprise August injunction by a federal judge threw the field's future into question.
► On Wednesday at ScienceInsider, Tania Rabesandratana reported from Brussels that the European Commission has denied a request by a citizens» initiative to «block E.U.
funding for research using
embryonic stem cells.»
A Washington, D.C., judge said this afternoon that his ruling 2 weeks ago, halting all federal
funding for human
embryonic stem cell research, will stand while the case moves forward.
In late 2004, California voters approved Proposition 71, allocating $ 3 billion over 10 years, making California the largest single
funder of
embryonic and pluripotent
stem cell research in the world and consequently one of the strongest job markets
for regenerative
research.
This set the stage
for a relatively restrictive environment
for embryonic (although not adult)
stem cell research in the United States relative to some other countries — the National Institutes of Health currently
funds between about $ 600 miilion to $ 700 million a year in
stem cell research.
Research on
embryonic stem cells funded by the U.S. government must stop immediately
for a court - ordered review, Judge Royce Lamberth of the U.S. District Court
for the District of Columbia ruled today.
The final guidelines on
research with human
embryonic stem cells issued on Monday by the National Institutes of Health set out criteria
for determining which ES
cell lines can be used in federally
funded experiments and give NIH discretion to approve old lines that don't meet stringent modern ethical requirements.
The bill was put forth to loosen the restrictions Bush placed on human
embryonic stem cell research on August 9, 2001, when he banned federal
funding for work with any
stem cell line created after that date.
The National Institutes of Health (NIH) is scrambling to push out
research grants
for work on human
embryonic stem cells (hESCs) and has given a cautious all - clear to in - house
stem cell researchers after an appeals court yesterday temporarily lifted a ban on federal
funding for hESC
research.
In the latest twist in an increasingly complex legal struggle, the Department of Justice (DOJ) has appealed a judge's refusal on Tuesday to remove the ban on
funding for human
embryonic stem cell (hESC)
research.
«We are in an era where the primary issues are not federal
funding for human
embryonic stem cell research,» wrote CAMR President Amy Comstock Rick, who is also CEO of the Parkinson's Action Network, in an e-mail to the more than 100 patient advocacy, scientific, and other groups that belong to CAMR.
In March, President Barack Obama lifted Bush's ban on using federal
funds for research on human
embryonic stem cells derived after August 2001.
But last April he also voted
for the HOPEAct, a Bush - supported «compromise» bill that would open up federal
funding for research that does not involve the creation, destruction, or injury of embryos; seeing as there are not yet any
embryonic stem cells lines that meet this condition (ACT hasn't yet proven that their technique poses no «risk of injury»), the HOPE
funding would only be available
for non-
embryonic stemcells.
Obama and Clinton both voted
for the
Stem Cell Research Enhancement Act, which would have broadly extended federal funding to human embryonic stem cell lines but was vetoed by Bush in 2006 and 2
Stem Cell Research Enhancement Act, which would have broadly extended federal funding to human embryonic stem cell lines but was vetoed by Bush in 2006 and 2
Cell Research Enhancement Act, which would have broadly extended federal
funding to human
embryonic stem cell lines but was vetoed by Bush in 2006 and 2
stem cell lines but was vetoed by Bush in 2006 and 2
cell lines but was vetoed by Bush in 2006 and 2007.
Lamberth, who ordered a temporary ban on federal
funding for human
embryonic stem cells research last August that an appeals court later overturned, is expected to issue a final ruling on the matter as soon as this summer.
U.S. Supreme Court rejects petition calling
for ban on taxpayer -
funded human
embryonic stem cell research
The 2012 platform also repeats previous calls
for expanding federal
funding «
for the
stem -
cell research that now offers the greatest hope
for many afflictions — with adult
stem cells, umbilical cord blood, and
cells reprogrammed into pluripotent
stem cells — without the destruction of
embryonic human life.»
If dealing with the public relations nightmare over its on - off - on
funding of Planned Parenthood wasn't enough, the Susan G. Komen
for the Cure cancer charity last week also got entangled, somewhat bizarrely, in the debate over human
embryonic stem (ES)
cell research.
A U.S. appeals court today upheld the legality of federally
funded research on human
embryonic stem cells (hESCs)-- the latest in a string of wins
for the National Institutes of Health (NIH) in a 3 - year legal battle with groups that
for moral reasons want to block the use of these
cells.
Since its inception, CIRM has sought to create a system from the ground up
for funding research on human
embryonic stem cells to fill in the gaps left by federal
funding restrictions (ScienceNOW, 12 April).
\ n \ nWhile historically there had been a ban on taxpayer
funding of
embryonic stem cell research, there has never been a ban on private
funding in this country and many European countries have allowed this type of
research for years, but so far none of this
research has yielded a single therapeutic use.
Twenty - seven human
embryonic stem cell (hESC) lines are ethically derived and should be approved
for use in
research funded by the US linkurl: National Institutes of Health; http://www.nih.gov/ (NIH), a committee advising the NIH director linkurl: recommended today (December 4).
February 2010 - Italian
stem cell scientists challenge goverment EuroSyStem scientist Elena Cattaneo challenges Italian government - the story continues In the summer of 2009, three Italian
stem celli scientists unsuccessfully challenged their government in the courts over its decision to exclude human
embryonic stem cell research from a ministerial
funding call
for projects on
stem cell biology.
The Coalition
for the Advancement of Medical
Research argues that seven in ten Americans want to eliminate restrictions on public funding of embryonic stem cell research, while the Conference of Catholic Bishops points to a poll showing six in ten oppose such funding alt
Research argues that seven in ten Americans want to eliminate restrictions on public
funding of
embryonic stem cell research, while the Conference of Catholic Bishops points to a poll showing six in ten oppose such funding alt
research, while the Conference of Catholic Bishops points to a poll showing six in ten oppose such
funding altogether.
Bush sought to honor the spirit, if not, perhaps, the letter, of Dickey - Wicker by providing
funding for embryonic stem -
cell research without incentivizing further embryo destruction.
The birthday greeting contained an unintended irony,
for while CIRM was approved by California voters a decade ago to give priority
funding to human
embryonic stem cell research, eight of the 10 approved clinical trials referenced by City of Hope were
for research projects using adult and other non-
embryonic stem cells.
Tarne demonstrates that
funding has moved from grants directed primarily towards
embryonic stem cell research toward primarily ethical
stem cells research — which has been the only
stem cell research to date to result in positive treatments
for illnesses.
This was the position taken by then President Clinton's National Bioethics Advisory Commission (NBAC), the first presidential bioethics panel to recommend federal
funding for human
embryonic stem cell research (hESCR).
Specter on Monday introduced a bill that affirmatively states that it is legal
for the government to
fund human
embryonic stem cell research — a bill highly similar to the one introduced in the House in March by Diana DeGette (Democrat, Colorado), with one important extra: Specter's bill states that the government should
fund the
research «notwithstanding any other provision of law, including [the Dickey - Wicker amendment].»
In 2014, Minnesota became the most recent of a handful of states that provide state
funding for all types of
stem cell research, including human
embryonic stem cell research.
Organized by the South Dakotans
for Lifesaving Cures, the petition drive comes eight months after President Barack Obama overturned a 2001 order by then - President George W. Bush that barred the National Institutes of Health from
funding embryonic stem cell research beyond the existing
stem cell lines.
The order severely restricts
embryonic stem cell research to existing lines of
cells and bans federal
funding for any
research expansion outside his directive.
Last week, a ruling by federal Judge Royce C. Lamberth left many human
embryonic stem cell (hESC) researchers not only scrambling
for funding and concerned about the future of their own
research, but also concerned
for the future of the whole field in this country.
The legislation would have eased restrictions on federal
funding for embryonic stem -
cell research.
The previous NIH -
funded National
Stem Cell Bank (NSCB) offered embryonic stem cells at $ 500 for two vials of cells through the non-profit organization WiCell Research Institute, but following the end of the NSCB, WiCell now charges $ 1000 / vial to cover co
Stem Cell Bank (NSCB) offered
embryonic stem cells at $ 500 for two vials of cells through the non-profit organization WiCell Research Institute, but following the end of the NSCB, WiCell now charges $ 1000 / vial to cover co
stem cells at $ 500
for two vials of
cells through the non-profit organization WiCell
Research Institute, but following the end of the NSCB, WiCell now charges $ 1000 / vial to cover costs.